|
Males |
Females |
Overall |
p ▪ |
Age (mean±SD) |
68.17±10.7 |
67.41±13 |
68±11 |
0.44 |
Smoking |
95% |
16% |
80.6% |
<0.001 |
Packs/year |
61.3±29.1 |
36.18±18.9 |
60.52±29 |
<0.001 |
Histology |
|
|
|
|
Adenocarcinoma |
24% |
50.3% |
27.9% |
<0.001 |
Squamous cell |
45.4% |
11.6% |
40.5% |
|
Small cell |
23% |
23.1% |
22.9% |
|
Others ▪ |
7.6% |
15.4% |
8.7% |
|
Stage |
|
|
|
|
I,II |
20.5% |
18.9% |
20.4% |
0.009 |
IIIA,IIIB |
46.2% |
35% |
44.5% |
|
IV |
33.3% |
46.2% |
31.1% |
|
|
? SD: standard deviation
? p: statistical significance for the comparison between the two sexes
? Others: adenosquamous, large cell, undifferentiated, carcinoid |
| Table 1: Overall and sex-related epidemiological and clinical characteristics of the
patients. |
